JP Stock MarketDetailed Quotes

Astellas Pharma (4503)

Watchlist
  • 2288.0
  • +81.0+3.67%
20min DelayTrading May 7 13:50 JST
4.14TMarket Cap14.10P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astellas Pharma (4503) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2026
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
11.87%2.14T
6.91%505.79B
19.25%1.91T
26.17%473.12B
5.60%1.6T
414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
Cost of revenue
16.96%408.43B
4.05%94.83B
19.39%349.21B
32.18%91.14B
1.43%292.49B
73.23B
1.98%75.9B
18.52%74.41B
-22.42%68.95B
13.97%288.35B
Gross profit
10.73%1.73T
7.59%410.97B
19.21%1.56T
24.82%381.99B
6.58%1.31T
341.37B
5.58%346.04B
0.04%317.74B
4.48%306.04B
17.94%1.23T
Operating expense
-11.30%1.35T
-4.71%318.42B
17.85%1.52T
28.04%334.17B
17.61%1.29T
387.27B
23.00%327.17B
38.16%320.95B
0.27%260.99B
20.45%1.1T
Selling and administrative expenses
2.05%860.31B
-4.78%197B
13.91%843.03B
23.01%206.88B
17.43%740.11B
--193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
-General and administrative expense
2.05%860.31B
-4.78%197B
13.91%843.03B
23.01%206.88B
17.43%740.11B
--193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
Research and development costs
-3.91%314.83B
-17.42%71.7B
11.38%327.65B
34.41%86.82B
6.54%294.19B
--77.85B
11.23%74.39B
18.70%77.36B
-12.72%64.59B
12.24%276.13B
Depreciation and amortization
-0.57%135.98B
-6.36%32.77B
38.40%136.76B
285.88%34.99B
157.10%98.82B
--32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
-0.57%135.98B
-6.36%32.77B
38.40%136.76B
285.88%34.99B
157.10%98.82B
--32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
Other operating expenses
-69.27%72.44B
105.54%21.33B
40.49%235.77B
-54.99%10.38B
6.54%167.81B
--83.84B
-16.34%23.41B
1,106.04%42.94B
-40.00%23.06B
51.00%157.52B
Total other operating income
61.23%32.8B
-10.80%4.37B
134.08%20.34B
25.16%4.9B
138.63%8.69B
--220M
136.65%2.57B
1,454.98%3.28B
-75.97%3.92B
-76.13%3.64B
Operating profit
844.29%380.06B
93.52%92.54B
112.42%40.25B
6.13%47.82B
-85.60%18.95B
-45.9B
-69.45%18.87B
-103.77%-3.22B
38.09%45.06B
0.45%131.56B
Net non-operating interest income (expenses)
38.33%-6.05B
-2,511.73%-4.23B
-1,682.36%-9.8B
-115.34%-162M
17.79%-550M
-62M
-1.23%-1.65B
-94.90%105M
171.89%1.06B
-155.75%-669M
Non-operating interest income
1.93%8.03B
-61.53%1.67B
-31.26%7.87B
14.75%4.33B
41.25%11.46B
--4.12B
0.60%1.18B
-33.41%2.37B
307.34%3.78B
31.89%8.11B
Non-operating interest expense
-20.39%14.07B
31.21%5.9B
47.25%17.68B
65.26%4.5B
36.75%12.01B
--4.19B
0.96%2.83B
50.46%2.27B
13.52%2.72B
77.39%8.78B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
-585.33%-1.78B
-182.58%-1.59B
91.82%-259M
181.20%1.93B
-351.19%-3.17B
-2.7B
45.21%-223M
-164.59%-923M
96.00%686M
157.67%1.26B
Special income (charges)
314.59%4.35B
307.04%3.7B
-89.22%1.05B
1,583.33%909M
4,491.98%9.74B
0
783.33%318M
468,100.00%9.36B
-68.24%54M
-99.13%212M
Less:Other special charges
-314.59%-4.35B
-307.04%-3.7B
89.22%-1.05B
-1,583.33%-909M
-4,491.98%-9.74B
--0
-783.33%-318M
-468,100.00%-9.36B
68.24%-54M
99.13%-212M
Other non-operating income (expenses)
Income before tax
1,105.58%376.59B
79.06%90.42B
25.10%31.24B
7.78%50.5B
-81.14%24.97B
-48.66B
-71.03%17.31B
-94.00%5.33B
47.89%46.85B
-15.63%132.36B
Income tax
535.74%85.01B
70.60%21.99B
-346.21%-19.51B
-6.04%12.89B
-76.45%7.92B
-15.38B
-75.34%2.8B
-60.49%6.79B
99.81%13.72B
2.58%33.65B
Net income
474.57%291.58B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Net income continuous operations
474.56%291.57B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
---33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Noncontrolling interests
Net income attributable to the company
474.57%291.58B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
474.57%291.58B
81.96%68.42B
197.72%50.75B
13.50%37.6B
-82.73%17.05B
-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
Gross dividend payment
Basic earnings per share
474.14%162.77
82.00%38.22
198.11%28.35
13.76%21
-82.47%9.51
-18.55
-69.54%8.09
-102.06%-0.81
35.84%18.46
-19.14%54.24
Diluted earnings per share
474.43%162.22
82.00%38.11
198.20%28.24
13.68%20.94
-82.49%9.47
-18.55
-69.64%8.06
-102.06%-0.81
35.54%18.42
-19.33%54.09
Dividend per share
5.41%78
0
5.71%74
0
16.67%70
35
0
16.67%35
0
20.00%60
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2026(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 11.87%2.14T6.91%505.79B19.25%1.91T26.17%473.12B5.60%1.6T414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T
Cost of revenue 16.96%408.43B4.05%94.83B19.39%349.21B32.18%91.14B1.43%292.49B73.23B1.98%75.9B18.52%74.41B-22.42%68.95B13.97%288.35B
Gross profit 10.73%1.73T7.59%410.97B19.21%1.56T24.82%381.99B6.58%1.31T341.37B5.58%346.04B0.04%317.74B4.48%306.04B17.94%1.23T
Operating expense -11.30%1.35T-4.71%318.42B17.85%1.52T28.04%334.17B17.61%1.29T387.27B23.00%327.17B38.16%320.95B0.27%260.99B20.45%1.1T
Selling and administrative expenses 2.05%860.31B-4.78%197B13.91%843.03B23.01%206.88B17.43%740.11B--193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B
-General and administrative expense 2.05%860.31B-4.78%197B13.91%843.03B23.01%206.88B17.43%740.11B--193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B
Research and development costs -3.91%314.83B-17.42%71.7B11.38%327.65B34.41%86.82B6.54%294.19B--77.85B11.23%74.39B18.70%77.36B-12.72%64.59B12.24%276.13B
Depreciation and amortization -0.57%135.98B-6.36%32.77B38.40%136.76B285.88%34.99B157.10%98.82B--32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B
-Depreciation --0--0--0--0--0--0--0--0--0--0
-Amortization -0.57%135.98B-6.36%32.77B38.40%136.76B285.88%34.99B157.10%98.82B--32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B
Other operating expenses -69.27%72.44B105.54%21.33B40.49%235.77B-54.99%10.38B6.54%167.81B--83.84B-16.34%23.41B1,106.04%42.94B-40.00%23.06B51.00%157.52B
Total other operating income 61.23%32.8B-10.80%4.37B134.08%20.34B25.16%4.9B138.63%8.69B--220M136.65%2.57B1,454.98%3.28B-75.97%3.92B-76.13%3.64B
Operating profit 844.29%380.06B93.52%92.54B112.42%40.25B6.13%47.82B-85.60%18.95B-45.9B-69.45%18.87B-103.77%-3.22B38.09%45.06B0.45%131.56B
Net non-operating interest income (expenses) 38.33%-6.05B-2,511.73%-4.23B-1,682.36%-9.8B-115.34%-162M17.79%-550M-62M-1.23%-1.65B-94.90%105M171.89%1.06B-155.75%-669M
Non-operating interest income 1.93%8.03B-61.53%1.67B-31.26%7.87B14.75%4.33B41.25%11.46B--4.12B0.60%1.18B-33.41%2.37B307.34%3.78B31.89%8.11B
Non-operating interest expense -20.39%14.07B31.21%5.9B47.25%17.68B65.26%4.5B36.75%12.01B--4.19B0.96%2.83B50.46%2.27B13.52%2.72B77.39%8.78B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests -585.33%-1.78B-182.58%-1.59B91.82%-259M181.20%1.93B-351.19%-3.17B-2.7B45.21%-223M-164.59%-923M96.00%686M157.67%1.26B
Special income (charges) 314.59%4.35B307.04%3.7B-89.22%1.05B1,583.33%909M4,491.98%9.74B0783.33%318M468,100.00%9.36B-68.24%54M-99.13%212M
Less:Other special charges -314.59%-4.35B-307.04%-3.7B89.22%-1.05B-1,583.33%-909M-4,491.98%-9.74B--0-783.33%-318M-468,100.00%-9.36B68.24%-54M99.13%-212M
Other non-operating income (expenses)
Income before tax 1,105.58%376.59B79.06%90.42B25.10%31.24B7.78%50.5B-81.14%24.97B-48.66B-71.03%17.31B-94.00%5.33B47.89%46.85B-15.63%132.36B
Income tax 535.74%85.01B70.60%21.99B-346.21%-19.51B-6.04%12.89B-76.45%7.92B-15.38B-75.34%2.8B-60.49%6.79B99.81%13.72B2.58%33.65B
Net income 474.57%291.58B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Net income continuous operations 474.56%291.57B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B---33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Noncontrolling interests
Net income attributable to the company 474.57%291.58B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 474.57%291.58B81.96%68.42B197.72%50.75B13.50%37.6B-82.73%17.05B-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B
Gross dividend payment
Basic earnings per share 474.14%162.7782.00%38.22198.11%28.3513.76%21-82.47%9.51-18.55-69.54%8.09-102.06%-0.8135.84%18.46-19.14%54.24
Diluted earnings per share 474.43%162.2282.00%38.11198.20%28.2413.68%20.94-82.49%9.47-18.55-69.64%8.06-102.06%-0.8135.54%18.42-19.33%54.09
Dividend per share 5.41%7805.71%74016.67%7035016.67%35020.00%60
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.02%
Sample Name
Sample Code
 +2.83%
Sample Name
Sample Code
 +2.18%
4
SHANGHAI PECHEM
00338
+0.78%
5
SINOPEC CORP
00386
-1.06%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +68.99%
Sample Name
Sample Code
 +62.95%
Sample Name
Sample Code
 +44.40%
4
Emdoor Information
001314
+42.53%
5
Digital China Group
000034
+26.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -